Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor

Blood

Volumn 93, Issue 2, 1999, Pages 564-570

  Beguin S ^b   Kumar, R ^b   Keularts, I ^b   Seligsohn, U ^b   Coller, B S ^a   Hemker, H C ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; GLYCOPROTEIN IB; THROMBIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BERNARD SOULIER DISEASE; BLOOD CLOTTING; DISEASE ASSOCIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOCYTE AGGREGATION; THROMBOSIS; VON WILLEBRAND DISEASE;

EID: 0344389051     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.564.402k04_564_570     Document Type: Article

References (40)

1. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS: Inhibition of platelet-mediated, tissue factor-induced, thrombin generation by the mouse/human chimeric 7E3 anibody: Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". J Clin Invest 98:863, 1996
2. Schroit AJ, Zwaal RF: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1071:313, 1991
3. Basse F, Stout JG, Sims PJ, Wiedmer T: Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem 271:17205, 1996
4. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ: Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 272:18240, 1997
5. Kumar R, Béguin S, Hemker HC: The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 74:962, 1995
6. Béguin S, Kumar R: Thrombin, fibrin and platelets: A resonance loop in which von Willebrand factor is a necessary link [published erratum, 78:973, 1997]. Thromb Haemost 78:590, 1997
7. Hendrix H, Lindhout T, Mertens K, Engels W, Hemker HC: Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem 258:3637, 1983
8. Coller BS: A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet GPIIb/IIIa complex. J Clin Invest 76:101, 1985
9. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61:99, 1983
10. Coller BS, Beer JH, Scudder LE, Steinberg MH: Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIa mediated by adhesive proteins. Blood 74:182, 1989
11. Newman PJ, Seligsohn U, Lyman S, Coller BS: The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 88:3160, 1991
12. Eikenboom JC, Ploos vAH, Reitsma PH, Briet E: Mutations in severe, type III von Willebrand's disease in the Dutch population: Candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA. Thromb Haemost 68:448, 1992
13. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hofmann T: Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rates. J Clin Invest 83:288, 1989
14. Béguin S, Lindhout T, Hemker HC: The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 61:25, 1989
15. Hemker HC, Willems GM, Béguin S: A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 56:9, 1986
16. Hemker HC, Wielders S, Béguin S: The thrombin potential, a parameter to assess the effect of antithrombotic drugs on thrombin generation, in Bounameaux H, Samama M, ten Cate JW (eds): Fraxiparin. Schattaurer, 1990, p 89
17. Hemker HC: Thrombin generation, an essential step in haemostasis and thrombosis, in Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis. London, UK, Churchill Livingstone, 1993, p 477
18. Kawabata S, Morita T, Iwanaga S, Igarashi H: Staphylocoagulasebinding region in human prothrombin. J Biochem (Tokyo) 97:325, 1985
19. Coller BS, Cheresh DA, Asch E, Seligsohn U: Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 77:75, 1991
20. Loscalzo J, Inbal A, Handin RI: von Willebrand protein facilitates platelet incorporation into polymerizing fibrin. J Clin Invest 78:1112, 1986
21. Shattil SJ, Gao J, Kashiwagi H: Not just another pretty face: Regulation of platelet function at the cytoplasmic face of integrin alpha IIb beta 3. Thromb Haemost 78:220, 1997
22. Plow EF, McEver RP, Coller BS, Marguerie GA, Ginsbuig MH: Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor and thrombospondin on thrombin-stimulated human platelets. Blood 66:724, 1985
23. Tuszynski GP, Kornecki E, Cierniewski C, Knight LC, Koshy A, Srivastava S, Niewiarowski S, Walsh PN: Association of fibrin with the platelet cytoskeleton. J Biol Chem 259:5247, 1984
24. Hantgan RR: Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: Evidence for a common mechanism. Biochim Biophys Acta 968:24, 1988
25. Cohen I, Gerrard JM, White JG: Ultrastructure of clots during isometric contraction. J Cell Biol 91:775, 1982
26. Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG: Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 76:345, 1990
27. Jen CJ, Hu SJ, Wu HJ, Lin TS, Mao CW: Platelet-fibrin interaction in the suspension and under flow conditions. Adv Exp Med Biol 281:277, 1990
28. Bithell TC, Parekh SJ, Strong RR: Platelet-function studies in the Bernard-Soulier syndrome. Ann NY Acad Sci 201:145, 1972
29. Howard MA, Hutton RA, Hardisty RM: Hereditary giant platelet syndrome: A disorder of a new aspect of platelet function. BMJ 2:586, 1973
30. Weiss HJ, Tschopp TB, Baumgartner HR, Sussman II, Johnson MM, Egan JJ: Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med 57:920, 1974
31. Walsh PN, Mills DC, Pareti FI, Stewart GJ, MacFarlane DE, Johnson MM, Egan JJ: Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol 29:639, 1975
32. Caen J, Bellucci S: The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. Blood Cells 9:389, 1983
33. Blomback B: Fibrinogen and fibrin - proteins with complex roles in hemostasis and thrombosis. Thromb Res 83:1, 1996
34. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with proco-agulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691, 1994
35. Lee DH, Warkentin TE, Denomme GA, Hayward CP, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia: Detection of platelet microparticles using flow cytometry. Br J Haematol 95:724, 1996
36. Barry OP, Pratico D, Lawson JA, FitzGerald GA: Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99:2118, 1997
37. Barry OP, Pratico D, Savani RC, FitzGerald GA: Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102:136, 1998
38. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635, 1995
39. Jansson JH, Nilsson TK, Johnson O: von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 66:351, 1991
40. Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ: von Willebrand factor and factor VIII:C in acute cerebrovascular disease. Relationship to stroke subtype and mortality. Thromb Haemost 77:1104, 1997